Results 311 to 320 of about 838,425 (399)

Managing hydrocephalus in patients with leptomeningeal disease: A multicenter retrospective analysis

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Leptomeningeal disease is a highly palliative condition of tumor cell seeding that can cause symptomatic hydrocephalus. This multi‐center retrospective study of patients with leptomeningeal disease‐associated hydrocephalus compared the placement of ventriculoperitoneal shunts and Rickham reservoirs for cerebrospinal fluid drainage.
Obada T. Alhalabi   +19 more
wiley   +1 more source

Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates. [PDF]

open access: yesFuture Oncol
Park YH   +12 more
europepmc   +1 more source

Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage IV gastric cancer

open access: yesInternational Journal of Cancer, EarlyView.
What's New? In selected patients with stage IV gastric cancer, radical surgery after conversion therapy may increase survival benefit; however, there is currently no standard protocol for conversion therapy. This prospective, single‐arm, single‐center, phase 2 study evaluated the feasibility of adding immunotherapy to a conversion treatment regimen to ...
Yong Liu   +17 more
wiley   +1 more source

Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double‐blind, randomized controlled DHA‐WIN trial

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Omega‐3 docosahexaenoic acid (DHA) has shown pleiotropic anti‐cancer effects both in vitro and in animal models. However, clinical evidence of DHA efficacy is limited. This randomized, double‐blind, placebo‐controlled trial tested the efficacy of supplementation with DHA 4.4 g/day during 18 weeks of breast cancer neoadjuvant chemotherapy ...
Jaqueline Munhoz   +16 more
wiley   +1 more source

Expert Consensus Guidance on the Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. [PDF]

open access: yesCureus
Dhabhar B   +10 more
europepmc   +1 more source

Real‐world study on fluoropyrimidine‐related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype‐guided dosing

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Fluoropyrimidines, a key component of chemotherapy regimens for a variety of solid tumors, can cause severe toxicity. Patients who have specific genetic variants in the DPYD gene, which encodes an enzyme that inactivates fluoropyrimidines, have increased susceptibility to this toxicity.
Sofía L. J. Peeters   +12 more
wiley   +1 more source

Patient‐reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trials

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The Quality of Life Questionnaire Core 30 (QLQ‐C30) is useful for assessing patient perspectives on the impact of cancer treatments on quality of life. However, thresholds to determine when patients are experiencing functional or symptomatic burdens remain under explored.
Bradley D. Menz   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy